US Stock MarketDetailed Quotes

INM InMed Pharmaceuticals

Watchlist
  • 0.2478
  • -0.0038-1.51%
Close Jul 2 16:00 ET
2.21MMarket Cap-458P/E (TTM)

InMed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

InMed Pharmaceuticals Earnings Date

Currency: USD

Period

Q3 FY2024 Earnings

--

Revenue(YoY)

1.17M

+13.41%
EPS(YoY)

-0.18

+70.00%
Analyst Rating

No Data

InMed Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CAD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.407M--
--2024/Q31.601M / 2.005M--
--2024/Q21.682M / 1.518M--
--2024/Q11.243M / 1.895M--
--2023/Q43.126M / 3.039M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 2.407M--
--2024/Q31.601M / 2.005M--
--2024/Q21.682M / 1.518M--
--2024/Q11.243M / 1.895M--
--2023/Q43.126M / 3.039M--

Unlock Free Earnings Estimates

InMed Pharmaceuticals Earnings Reports

  • InMed Pharmaceuticals | 10-Q: Quarterly report

    May 14 12:35 ET

  • InMed Pharmaceuticals | 10-Q: Quarterly report

    Feb 13 18:06 ET

  • InMed Pharmaceuticals | 10-K/A: Annual report (Amendment)

    Dec 21, 2023 17:21 ET

  • InMed Pharmaceuticals: Q1 2024 Earnings Report

    Nov 13, 2023 17:34 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg